{"disease":{"id":"telangiectasia","name":"telangiectasia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01158807","title":"Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2272,"lead_sponsor_name":"Unity Health Toronto","has_results":false},{"nct_id":"NCT05978986","title":"Efficiency of Determining the Clinical Class of Chronic Venous Disorders by Artificial Intelligence","phase":"NA","overall_status":"COMPLETED","enrollment_count":1622,"lead_sponsor_name":"Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia","has_results":false},{"nct_id":"NCT03646955","title":"Partial Breast Versus no Irradiation for Women With Early Breast Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":926,"lead_sponsor_name":"Danish Breast Cancer Cooperative Group","has_results":false},{"nct_id":"NCT03695874","title":"Development of a Quality of Life Measurement Scale in Hereditary Haemorrhagic Telangiectasia (HHT) Disease.","phase":"","overall_status":"COMPLETED","enrollment_count":643,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06573723","title":"Institutional Registry of Rare Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":380,"lead_sponsor_name":"Hospital Italiano de Buenos Aires","has_results":false},{"nct_id":"NCT07101575","title":"Cardiac Evaluation in Hereditary Hemorrhagic Telangiectasia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":380,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT00684879","title":"Screening Behavior in Adults With Hereditary Hemorrhagic Telangiectasia","phase":"","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT05933330","title":"Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Odense University Hospital","has_results":false},{"nct_id":"NCT04150822","title":"CHORUS - Comprehensive HHT Outcomes Registry of the United States (Formerly OUR HHT Registry)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":296,"lead_sponsor_name":"Unity Health Toronto","has_results":false},{"nct_id":"NCT06971939","title":"Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":285,"lead_sponsor_name":"Neurotech Pharmaceuticals","has_results":false},{"nct_id":"NCT06261333","title":"Quality of Life in Patients With Hemorrhagic Telangiectasia","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":250,"lead_sponsor_name":"University Hospital, Essen","has_results":false},{"nct_id":"NCT04037189","title":"Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Rabin Medical Center","has_results":false},{"nct_id":"NCT03691142","title":"Evaluation of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT)","phase":"","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07191639","title":"Description of the Impact of Symptoms on Quality of Life in HHT Disease: DISQUO","phase":"","overall_status":"COMPLETED","enrollment_count":185,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04991701","title":"A National Retrospective Population Based Cohort Study of the Natural History of Ataxia Telangiectasia","phase":"","overall_status":"UNKNOWN","enrollment_count":178,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT03940014","title":"Pulmonary Arteriovenous Malformations (PAVMs) in Hereditary Haemorrhagic Telangiectasia (HHT)","phase":"","overall_status":"COMPLETED","enrollment_count":170,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07111598","title":"Immunological Effects of Iron Supplementation in HHT Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":155,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04795310","title":"Clinical Observation of Pulsed Dye Laser and Intense Pulsed Light in Treating Facial Telangiectasia","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT03910244","title":"Pomalidomide for the Treatment of Bleeding in HHT","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"The Cleveland Clinic","has_results":true},{"nct_id":"NCT07499999","title":"Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":140,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT03316300","title":"A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Neurotech Pharmaceuticals","has_results":true},{"nct_id":"NCT06659640","title":"A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Alnylam Pharmaceuticals","has_results":false},{"nct_id":"NCT03319849","title":"A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":119,"lead_sponsor_name":"Neurotech Pharmaceuticals","has_results":true},{"nct_id":"NCT06193200","title":"Evaluate the Neurological Effects of EryDex on Subjects With A-T","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Quince Therapeutics S.p.A.","has_results":false},{"nct_id":"NCT03563053","title":"Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":104,"lead_sponsor_name":"Quince Therapeutics S.p.A.","has_results":true},{"nct_id":"NCT06664853","title":"Open-Label Extension of EryDex Study IEDAT-04-2022","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":101,"lead_sponsor_name":"Quince Therapeutics S.p.A.","has_results":false},{"nct_id":"NCT04469517","title":"Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University Hospital, Essen","has_results":false},{"nct_id":"NCT05550376","title":"Genotype-phenotype Association in Hereditary Hemorrhagic Telangiectasia","phase":"","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","has_results":false},{"nct_id":"NCT06582043","title":"Evaluation of the Efficacy and Tolerance of Two Cosmetic Products in Subjects With Rosacea","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"NAOS Argentina S.A.","has_results":false},{"nct_id":"NCT03071965","title":"Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Neurotech Pharmaceuticals","has_results":true},{"nct_id":"NCT07018401","title":"Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia Longitudinal Assessment Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":62,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03954782","title":"Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03841422","title":"Evaluation of Video-assisted Instructions of Nasal Self-packing in Patients with HHT","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"University Hospital, Essen","has_results":false},{"nct_id":"NCT06673056","title":"A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"IntraBio Inc","has_results":false},{"nct_id":"NCT03572556","title":"Prospective Descriptive Study of the Angiogenic T Cell Population in Subjects With Hereditary Hemorrhagic Telangiectasia (HHT)","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT03981562","title":"Vitamin D and Hereditary Haemorrhagic Telangiectasia","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"St. Paul's Hospital, Canada","has_results":false},{"nct_id":"NCT04336163","title":"Skin Imaging to Inform Laser Treatments","phase":"NA","overall_status":"TERMINATED","enrollment_count":55,"lead_sponsor_name":"University of California, Irvine","has_results":true},{"nct_id":"NCT03152019","title":"Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":true},{"nct_id":"NCT05752253","title":"Counseling Intervention in Hereditary Hemorrhagic Telangiectasia in the COVID Era.","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05531890","title":"Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":48,"lead_sponsor_name":"Grace Therapeutics Inc.","has_results":false},{"nct_id":"NCT05954481","title":"Stress-Echography in Hereditary Haemorrhagic Telangiectasia Patient With Hepatic Involvement","phase":"NA","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06962813","title":"Transdermal Radiofrequency V ERASER Versus Polidocanol Sclerotherapy for Reticular Veins and Telangiectasias","phase":"NA","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Science Valley Research Institute","has_results":false},{"nct_id":"NCT04108052","title":"Diagnostic Value of Ultra-low Dose Thoracic Scanner for the Pulmonary Arteriovenous Malformation Detection in HHT Patient","phase":"NA","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05692622","title":"Home-based Complex Intervention for Children With Ataxia Telangiectasia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"University of Plymouth","has_results":false},{"nct_id":"NCT04605523","title":"Neurofilament Light- Chain in Ataxia Telangiectasia","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Johann Wolfgang Goethe University Hospital","has_results":false},{"nct_id":"NCT07414446","title":"Non-Invasive Detection of Pulmonary Right-to-Left Shunts Using the SONAS Ultrasound Device","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"St. Antonius Hospital","has_results":false},{"nct_id":"NCT02389959","title":"Intranasal Bevacizumab for HHT-Related Epistaxis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Stanford University","has_results":true},{"nct_id":"NCT04729972","title":"Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Neurotech Pharmaceuticals","has_results":true},{"nct_id":"NCT04404881","title":"Bevacizumab In Hereditary Hemorrhagic Telangiectasia","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":33,"lead_sponsor_name":"Hanny Al-Samkari, MD","has_results":false},{"nct_id":"NCT05252819","title":"Whole Body MRI for Cancer Surveillance in A-T","phase":"","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"University of Nottingham","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}